Linda and Chunmin’s patent application was granted – congratulations Linda and Chunmin!
Epigenomic editing and reactivation of targets for the treatment of Fragile X syndrome, US Patent 17689867, October 13, 2022. https://patents.google.com/patent/US20220323553A1/en